Skip to main content
Premium Trial:

Request an Annual Quote

Inova to Use GenoSpace Platform for Whole-Genome Sequencing Project

NEW YORK (GenomeWeb) –Inova Health System, a not-for-profit healthcare system in Washington, DC, will use GenoSpace's Population Analytics platform to analyze and explore clinical and genomic data from an ongoing whole-genome sequencing initiative, GenoSpace said today.

Greg Eley, chief technology officer of the Inova Translational Medicine Institute, a division of the larger Inova system, said in a statement that Inova selected GenoSpace's product because of its analytical capabilities and the company's experience serving customers in R&D and clinical care.

To date, the ITMI has sequenced more than 8,000 genomes from individuals representing more than 100 countries and expects to have sequenced roughly 20,000 genomes by the end of 2015. These sequences have been linked to extensive clinical data with the goal of discovering genetic factors contributing to a wide range of diseases.

"We needed an effective solution to the challenge of making petabytes of genomic data accessible to the scientists and physicians in our organization," Eley said.  GenoSpace's platform provides the tools needed by Inova staff "to efficiently gain insight from large quantities of complex information."

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.